Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Peripheral Artery Disease V: Postoperative Nursing Management

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...

Diabetic Foot Ulcer

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...

Veins of Lower Limbs

Veins of Lower Limbs

The human body consists of an intricate network of veins responsible for the crucial task of blood drainage from the lower limbs. These veins can be categorized into two main types: deep veins and superficial veins.
Formed by the union of the medial and lateral plantar veins, the posterior tibial vein, rising through the calf muscle, assimilates the fibular vein. The anterior tibial vein, a superior extension of the foot's dorsalis pedis vein, merges with the posterior tibial vein at the knee,...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Peripheral Artery Disease I: Introduction

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Implementation of a rapid continuous EEG monitoring program in a community hospital can decrease hospital to hospital transfers.

The American journal of emergency medicine·2025

Same author

Effect of ED Prompt on Improving Provider Documentation of Repeat Vital Signs in Children Presenting With Fever and Tachycardia.

American journal of medical quality : the official journal of the American College of Medical Quality·2025

Same author

Secondary Infection Risk in Patients With Severe COVID-19 Pneumonia Treated With Tocilizumab.

American journal of therapeutics·2022

Same author

Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2020

Same author

Fentanyl-Associated Serotonin Syndrome and Chest Wall Rigidity in an Intensive Care Unit Patient.

American journal of therapeutics·2018

Same author

Daily Informal Multidisciplinary Intensive Care Unit Operational Debriefing Provides Effective Support for Intensive Care Unit Nurses.

Dimensions of critical care nursing : DCCN·2016

Search research articles

Related Experiment Videos

Recurrent lower extremity pseudocellulitis.

Alex Korniyenko¹, James Lozada, Aditi Ranade

¹Department of Internal Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY 10025, USA. aleksandrmedic@hotmail.com

American Journal of Therapeutics

|July 10, 2012

Summary

Gemcitabine chemotherapy can cause pseudocellulitis, a noninfectious skin inflammation, particularly in areas of lymphedema. This condition is unrelated to radiation exposure and does not require antibiotics for treatment.

Related Experiment Videos

Area of Science:

Oncology
Dermatology
Pharmacology

Background:

Pseudocellulitis is a noninfectious inflammation of the dermis and hypodermis.
Chemotherapeutic agents can cause various cutaneous reactions.
Gemcitabine is a chemotherapy drug used for solid malignancies, often causing radiation recall dermatitis.

Observation:

A case of Gemcitabine-induced pseudocellulitis unrelated to radiation exposure is presented.
The pseudocellulitis manifested in an area of lymphedema.
This reaction may be linked to the drug's pharmacokinetics and its persistence in subcutaneous tissue.

Findings:

Gemcitabine can induce pseudocellulitis in non-irradiated lymphedematous tissue.
The condition is a noninfectious inflammatory response.
Antibiotics are ineffective; symptomatic treatment with antihistamines and NSAIDs may be used.

Implications:

Highlights a novel presentation of Gemcitabine-induced cutaneous toxicity.
Suggests a need to consider drug-induced pseudocellulitis in patients on Gemcitabine, especially with lymphedema.
Informs clinical management by differentiating from infectious cellulitis and guiding treatment strategies.